Ensure youre well-hydrated
Other Repair Peptides: Key Differences Researchers frequently evaluate this peptide alongside TB-500 (Thymosin Beta-4) and GHK-Cu, since these three compounds share broad tissue-repair research relevance
Several trials on other NMDA-modulating drugs, including ketamine, 504 riluzole, 44,505 and d-cycloserine, 506 have been negative for the primary endpoint, indicating that further studies with increased sample sizes are required
A few more data points are worth keeping in view because they round out the safety story
Many people notice an increase in energy and overall well-being shortly after receiving their injection, typically within 24-72 hours
Trial REDEFINE 2 Phase 3 Duration 68 weeks Population (N) 1,206 adults with T2D + obesity/overweight Key Result 13.7% mean weight change vs 3.4% placebo (treatment-policy)